CAMBRIDGE, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) today announced that Thomas Mathers, Chief Executive Officer, will present a corporate overview at the Stifel 2015 Healthcare Conference.
| Stifel 2015 Healthcare Conference | |
| Date: | Wednesday, November 18, 2015 |
| Time: | 8:00am Eastern Time |
| Location: | Hubbard Room, The New York Palace Hotel |
| Webcast: | http://www.veracast.com/webcasts/stifel/healthcare2015/05201687339.cfm |
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing oral lasmiditan for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of unspecified headache pain in adults in emergency room and other urgent care settings.